Evidence method
Level · gp.fundamentals.debt_to_revenue
46.66% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Sep 30, 2020
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-20-000057General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.67% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.64% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
20.15% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
53.81% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
35.51% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
18.10% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.28% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.82% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 48.60%
- Current
- 46.66%
- Delta
- -1.94%
- Previous
- 7.04%
- Current
- 8.67%
- Delta
- 1.63%
- Previous
- 28.09%
- Current
- 21.64%
- Delta
- -6.45%
- Previous
- 12.24%
- Current
- 20.15%
- Delta
- 7.91%
- Previous
- 52.12%
- Current
- 53.81%
- Delta
- 1.69%
- Previous
- 37.01%
- Current
- 35.51%
- Delta
- -1.50%
- Previous
- 19.65%
- Current
- 18.10%
- Delta
- -1.55%
- Previous
- 2.05%
- Current
- 2.28%
- Delta
- 0.23%
- Previous
- 2.31%
- Current
- 1.82%
- Delta
- -0.49%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_DECREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.